Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2646-2662
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2646
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2646
Figure 6 Knockdown of complement factor I inhibited tumor growth in colon cancer model mice.
A: Representative images of colon cancer (CC) xenograft tumors in the Lv-sh-NC and Lv-sh-complement factor I (CFI) groups; B: Tumor growth curves and weight determinations; C: The histological alterations in CC tumors were observed using hematoxylin and eosin staining; D: Immunohistochemistry was employed to measure Ki67 levels in the Lv-sh-NC and Lv-sh-CFI groups. cP < 0.001 vs Lv-sh-NC group (n = 6 mice per group). CFI: Complement factor I.
- Citation: Du YJ, Jiang Y, Hou YM, Shi YB. Complement factor I knockdown inhibits colon cancer development by affecting Wnt/β-catenin/c-Myc signaling pathway and glycolysis. World J Gastrointest Oncol 2024; 16(6): 2646-2662
- URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2646.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2646